Skip to main content
SpringerLink
Log in

Letter: Celiac Disease Presenting After a Single Anastomosis Duodeno-Ileal Bypass and Sleeve Gastrectomy

  • Letter to the Editor
  • Published:
Obesity Surgery Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Freeman LM, Strong AT, Sharma G, et al. Implications of celiac disease among patients undergoing gastric bypass. Obes Surg. 2018;28(6):1546–52. https://doi.org/10.1007/s11695-017-3046-2.

    Article  PubMed  Google Scholar 

  2. Jamma S, Rubio-Tapia A, Kelly CP, et al. Celiac crisis is a rare but serious complication of celiac disease in adults. Clin Gastroenterol Hepatol. 2010;8(7):587–90. https://doi.org/10.1016/j.cgh.2010.04.009.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Maple JT, Pearson RK, Murray JA, et al. Silent celiac disease activated by pancreaticoduodenectomy. Dig Dis Sci. 2007;52(9):2140–4. https://doi.org/10.1007/s10620-006-9598-y.

    Article  PubMed  Google Scholar 

  4. Cuenca-Abente F, Nachman F, Bai JC. Diagnosis of celiac disease during pre-operative work-up for bariatric surgery. Acta Gastroenterol Latinoam. 2012;42(4):321–4.

    PubMed  Google Scholar 

  5. Pane A, Orois A, Careaga M, et al. Clinical onset of celiac disease after duodenal switch: a case report. Eur J Clin Nutr. 2016;70(9):1078–9. https://doi.org/10.1038/ejcn.2016.65.

    Article  CAS  PubMed  Google Scholar 

  6. Marini JM, Coghlan E, Laferrere L, et al. Severe malnutrition and celiac disease following gastric bypass surgery. Int J Case Reports Med. 2014;2014:1–5. https://doi.org/10.5171/2014.130992.

    Article  Google Scholar 

  7. Ukkola A, Maki M, Kurppa K, et al. Changes in body mass index on a gluten-free diet in coeliac disease: a nationwide study. Eur J Intern Med. 2012;23(4):384–8. https://doi.org/10.1016/j.ejim.2011.12.012.

    Article  PubMed  Google Scholar 

  8. de Angelis N, Carra MC, Vincenzi F. Gluten-free diet in obese patients with celiac disease: an enemy of the bariatric surgeon? Obes Surg. 2012;22(6):995–6. https://doi.org/10.1007/s11695-012-0626-z.

    Article  Google Scholar 

  9. Shoar S, Poliakin L, Rubenstein R, et al. Single anastomosis duodeno-ileal switch (SADIS): a systematic review of efficacy and safety. Obes Surg. 2018;28(1):104–13. https://doi.org/10.1007/s11695-017-2838-8.

    Article  PubMed  Google Scholar 

  10. Puzziferri N, Roshek 3rd TB, Mayo HG, et al. Long-term follow-up after bariatric surgery: a systematic review. JAMA. 2014;312(9):934–42. https://doi.org/10.1001/jama.2014.10706.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Costantino G, della Torre A, Lo Presti MA, et al. Treatment of life-threatening type I refractory coeliac disease with long-term infliximab. Dig Liver Dis. 2008;40(1):74–7. https://doi.org/10.1016/j.dld.2006.10.017.

    Article  CAS  PubMed  Google Scholar 

  12. Murray JA, Rubio-Tapia A, Van Dyke CT, et al. Mucosal atrophy in celiac disease: extent of involvement, correlation with clinical presentation, and response to treatment. Clin Gastroenterol Hepatol. 2008;6(2):186–93; quiz 25. https://doi.org/10.1016/j.cgh.2007.10.012.

    Article  PubMed  Google Scholar 

  13. Hoerter NA, Shannahan SE, Suarez J, et al. Diagnostic yield of isolated deamidated gliadin peptide antibody elevation for celiac disease. Dig Dis Sci. 2017;62(5):1272–6. https://doi.org/10.1007/s10620-017-4474-5.

    Article  CAS  PubMed  Google Scholar 

  14. de Chaisemartin L, Meatchi T, Malamut G, et al. Application of deamidated gliadin antibodies in the follow-up of treated celiac disease. PLoS One. 2015;10(8):e0136745. https://doi.org/10.1371/journal.pone.0136745.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Lau MS, Mooney PD, White WL, et al. The role of an IgA/IgG-deamidated gliadin peptide point-of-care test in predicting persistent villous atrophy in patients with celiac disease on a gluten-free diet. Am J Gastroenterol. 2017;112(12):1859–67. https://doi.org/10.1038/ajg.2017.357.

    Article  CAS  PubMed  Google Scholar 

  16. Tosco A, Maglio M, Paparo F, et al. Immunoglobulin A anti-tissue transglutaminase antibody deposits in the small intestinal mucosa of children with no villous atrophy. J Pediatr Gastroenterol Nutr. 2008;47(3):293–8. https://doi.org/10.1097/MPG.0b013e3181677067.

    Article  CAS  PubMed  Google Scholar 

  17. Gatti S, Rossi M, Alfonsi S, et al. Beyond the intestinal celiac mucosa: diagnostic role of anti-TG2 deposits, a systematic review. Front Med (Lausanne). 2014;1:9. https://doi.org/10.3389/fmed.2014.00009.

    Article  Google Scholar 

Download references

Acknowledgements

The authors would like to thank Monika Shpokayte for proofreading the manuscript.

Author information

Author notes

  1. Amelie Therrien

    Present address: Beth Israel Deaconess Medical Center, East Campus, Gastroenterology 330 Brookline Ave, Boston, MA, 02115, USA

  2. Marie-Pierre Renaud

    Present address: Hôpital Anna-Laberge, 200 Boul Brisebois, Châteauguay, J6K 4W8, Canada

Authors and Affiliations

  1. Department of Medicine, Division of Gastroenterology, Centre Hospitalier de l’Université de Montreal, 1051 Sanguinet, Montreal, H2X 0C1, Canada

    Amelie Therrien, Marie-Pierre Renaud, Louise D’Aoust & Michel Lemoyne

  2. Department of Pathology, Centre Hospitalier de l’Université de Montréal, 1100 rue Sanguinet, Pavillon F, Montreal, H2X 0C2, Canada

    Lilia-Maria Sanchez

Authors
  1. Amelie Therrien
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marie-Pierre Renaud
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lilia-Maria Sanchez
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Louise D’Aoust
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Michel Lemoyne
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

AT and ML wrote the letter. MPR and LD edited the letter. LMS interpreted the pathology slides. AT is the guarantor of the letter. All authors have approved the final letter.

Corresponding author

Correspondence to Amelie Therrien.

Ethics declarations

Conflict of Interest

The authors disclose no conflict of interest in relation to this work. Dr. Louise D’Aoust is on an advisory board for Shire for the use of teduglutide in short bowel syndrome. This research did not receive any specific grant from funding agencies in the public, commercial or not-for-profit sectors. Dr. Amelie Therrien was supported by phase 1 award from Fonds de Recherche Santé Québec (FRQS) Programme FRQS/MSSS de formation pour médecins résidents en médecine spécialisée visant une carrière en recherche.

Informed Consent

The patient written informed consent was obtained for the publication of this letter.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Therrien, A., Renaud, MP., Sanchez, LM. et al. Letter: Celiac Disease Presenting After a Single Anastomosis Duodeno-Ileal Bypass and Sleeve Gastrectomy. OBES SURG 29, 1018–1021 (2019). https://doi.org/10.1007/s11695-018-03678-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-018-03678-3

Search

Navigation